MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    Treatment of Parkinson’s disease psychosis–a systematic review of RCTs

    K. Cook, D. Nellesen, K. Adamski, A. Shim (Menlo Park, CA, USA)

    Objective: An SLR was conducted to assess the evidence from RCTs supporting the safety and efficacy of Parkinson’s disease psychosis (PDP) treatments. Background: PDP is…
  • 2017 International Congress

    Longitudinal analysis of the relation of dopamine agonist use with impulse control disorders in Parkinson’s disease

    j.-c. corvol, F. Artaud, O. Rascol, F. Durif, P. Derkinderen, F. Bourdain, J.-P. Brandel, f. Pico, L. Lacomblez, C. Bonnet, D. Grabli, S. Klebe, G. Mangone, H. You, v. Mesnage, P.C. Lee, A. Brice, M. Vidailhet, F. Cormier-Dequaire, A. Elbaz (Paris, France)

    Objective: To investigate the longitudinal relationship between dopaminergic therapies and impulse control disorders (ICD) in PD. Background: ICD are frequently associated with dopaminergic therapy, particularly dopamine…
  • 2017 International Congress

    Perceptions of Fluctuation Treatment in Parkinson’s Disease Impact Suicidality

    J. Hinkle, K. Perepezko, Z. Mari, L. Marsh, G. Pontone (Baltimore, MD, USA)

    Objective: Our goal was to examine the relationship between suicidality and motor fluctuations in Parkinson’s disease (PD) patients. Background: On/off motor fluctuations in PD are…
  • 2017 International Congress

    Domain-Specific Cognitive Impairment in Non-Demented Parkinson’s Disease Psychosis

    J. Hinkle, K. Perepezko, C. Bakker, T. Dawson, V. Johnson, Z. Mari, C. Marvel, K. Mills, A. Pantelyat, O. Pletnikova, L. Rosenthal, M. Shepard, D. Stevens, J. Troncoso, J. Wang, G. Pontone (Baltimore, MD, USA)

    Objective: Our objective was to determine whether psychosis in non-demented Parkinson’s disease (PD) patients is associated with domain-specific cognitive impairment on the Mini-Mental State Exam…
  • 2017 International Congress

    Othello syndrome amongst patients with Parkinson’s disease in a rural movement disorders clinic in western India

    S. Desai, D. Desai (Anand, India)

    Objective: To assess the prevalence of Othello syndrome amongst patients with Parkinson’s disease in a rural based movement disorders clinic.  Background:  Othello syndrome (OS) is…
  • 2017 International Congress

    Suicidality in Parkinson’s Disease: A Case Control Study

    M. Akbostanci, E. Bayram, D. Sayar, T. Ayidaga (Ankara, Turkey)

    Objective: To investigate suicidality in Parkinson's disease (PD) by a case control study Background: Depression, a risk factor for suicidality, is rather common in PD patients. Nevertheless,…
  • 2017 International Congress

    Short term effects of bilateral STN DBS on psychiatric profile in Parkinson’s disease

    R. Alugolu, M.B. Kesani, B. Ganji, V. Mudumba, R. Mrudula, R. Borgohain, P. Gaddamanugu (Hyderabad, India)

    Objective: We intend to look into the effects of bilateral STN DBS on Psychiatric profile of Parkinson’s patients. Background: Parkinson’s disease is a well-known degenerative…
  • 2017 International Congress

    Absence of depression in de novo Parkinson’s disease: a benign motor phenotype?

    H.S. YOO, Y. Lee, J.J. Lee, S.J. Chung, P.H. Lee, Y.H. Sohn (Seoul, Republic of Korea)

    Objective: This study aimed to assess the impact of early depression on motor deficits relative to the level of striatal dopaminergic depletion in patients with…
  • 2017 International Congress

    Improving Diagnosis and Treatment of Anxiety in Parkinson’s Disease: IDATA-PD Study

    N. Dissanayaka, N. Pachana, J. O'Sullivan, R. Marsh, P. Silburn, E. White, E. Torbey, D. Pye, L. Mitchell, J.H. Yang, T. Au, G. Mellick, D. Copland, A. Toft, G. Byrne (Brisbane, Australia)

    Objective: We investigated PD-specific features of anxiety for clear conceptualisation, and assessed targeted psychotherapy for anxiety in Parkinson’s disease (PD). Background: Anxiety is poorly diagnosed in PD…
  • 2017 International Congress

    Treatment of Psychosis in Parkinson’s Disease: Evidence-Based Recommendations Versus Actual Clinical Practice

    L.G. Chan, A. Kong, L. Tan (Singapore, Singapore)

    Objective: To examine if actual clinical practice of antipsychotic use in Parkinson's Disease patients are consistent with published evidence-based reviews of treatment recommendations and discuss…
  • « Previous Page
  • 1
  • …
  • 1685
  • 1686
  • 1687
  • 1688
  • 1689
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley